CGEN: CANCER GENOMICS AND EPIDEMIOLOGY NAVIGATOR

CGEN

Epidemiology and Genomics Research Program

Citation
Helzlsouer KJ et. al. Summary of the round table discussion on strategies for cancer prevention: diet, food, additives, supplements, and drugs. Cancer Res 1994 Apr 1;54(7 Suppl):2044s-2051s.
Patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2011 Mar;135(3):481; author reply 482-3.
Kinney W et. al. Special commentary: patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2010 Aug;134(2):193-9.
Qian H et. al. The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: a meta-analysis of clinical trials. BMC Cancer 2014;14:683.
Rivera DR et. al. Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development. Ann Pharmacother 2014 Mar;48(3):369-79.
Monami M et. al. Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials. Curr Med Res Opin 2011 Nov;27 Suppl 3:57-64.
O'Bryant CL et. al. A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state. Cancer Chemother Pharmacol 2009 Feb;63(3):477-89.
Huang M et. al. Metabolism of an Alkylated Polycyclic Aromatic Hydrocarbon 5-Methylchrysene in Human Hepatoma (HepG2) Cells. Chem Res Toxicol 2015 Oct 19;28(10):2045-58.
Jennison C et. al. Meta-analyses and adaptive group sequential designs in the clinical development process. J Biopharm Stat 2005;15(4):537-58.
Bode AM et. al. Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 2000 Nov;1:181-8.
Brown SL et. al. Silicone breast implants and autoimmune disease. J Am Med Womens Assoc 1998 Winter;53(1):21-4, 40.
Niraula S et. al. The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs. J Clin Oncol 2012 Aug 20;30(24):3012-9.
Bennett CL et. al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008 Feb 27;299(8):914-24.
Sun J et. al. Meta-analysis of randomized controlled trials on laparoscopic gastrectomy vs. open gastrectomy for distal gastric cancer. Hepatogastroenterology 2012 Sep;59(118):1699-705.
Wimmerová S et. al. The spatial distribution of human exposure to PCBs around a former production site in Slovakia. Environ Sci Pollut Res Int 2015 Oct;22(19):14405-15.
Ibrahim JG et. al. Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. Biometrics 2012 Jun;68(2):578-86.
Chen MH et. al. Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program. Stat Med 2014 Apr 30;33(9):1600-18.
Schutz FA et. al. Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors. J Clin Oncol 2012 Mar 10;30(8):871-7.
Nguyen PL et. al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA 2011 Dec 7;306(21):2359-66.
Qi WX et. al. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin 2013 Feb;29(2):117-25.